A Snapshot of What Pfizer's Doing with Teleoperated Robots
Teleoperated robots, which are remotely operated, can provide flexibility to operators when automation or isolators won’t suffice. Jean-Maxime Guay, Pfizer Senior Manager of Manufacturing Intelligence with Pfizer Canada, discusses how Pfizer is testing teleoperated robotic applications in this interview following his presentation on the topic at the 2025 ISPE Facilities of the Future Conference.
In the article that follows, Maxime briefly describes the technology and offers use case examples, shares some key considerations from integration, validation, and safety perspectives, and provides several suggestions for companies just starting to explore teleoperated robots. He also shares the value of using teleoperated robots in various operations and provides insight into what other critical areas he sees telemanipulation as offering a significant benefit within biopharmaceutical manufacturing.
Learn more about ISPE conferences.
About Biosimilar Development
Biosimilar Development is part of the Life Science Connect media group. The publication provides in-depth content from pharmaceutical experts who specialize in the biosimilars segment of the industry.